Oral administration of chymase inhibitor improves dermatitis in NC/Nga mice [2]

Journal of Investigative Dermatology

Volumn 127, Issue 4, 2007, Pages 971-973

  Watanabe, Naohiro ^a   Tomimori, Yoshiaki ^b   Terakawa, Maki ^b   Ishiwata, Kenji ^a   Wada, Adumi ^a   Muto, Tsuyoshi ^b   Tanaka, Taisaku ^b   Maruoka, Hiroshi ^b   Nagahira, Kazuhiro ^b   Nakatsuka, Takashi ^b   Fukuda, Yoshiaki ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; CHYMASE INHIBITOR; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR; SUN 13350; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; BACTERIAL PERITONITIS; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; EOSINOPHIL; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; LETTER; LEUKOCYTE MIGRATION; MAST CELL; MEDICAL ETHICS; MOLECULAR WEIGHT; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; AZEPINES; CHYMASES; DERMATITIS; ENZYME INHIBITORS; MICE; MICE, INBRED STRAINS;

EID: 33947236929     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700708     Document Type: Letter

References (12)

1. He S, Walls AF (1998) Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125:1491-500
2. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K et al. (1997) Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 94:9017-21
3. Mao XQ, Shirakawa T, Yoshikawa T, Yoshikawa K, Kawai M, Sasaki S et al. (1996) Association between genetic variants of mast-cell chymase and eczema. Lancet 348:581-3
4. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J et al. (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461-6
5. Tanaka K, Sugiura H, Uehara M, Sato H, Hashimoto-Tamaoki T, Furuyama J (1999) Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy 29:800-3
6. Tomimori Y, Muto T, Fukami H, Saito K, Horikawa C, Tsuruoka N et al. (2002a) Chymase participates in chronic dermatitis by inducing eosinophil infiltration. Lab Invest 82:789-94
7. Tomimori Y, Muto T, Fukami H, Saito K, Horikawa C, Tsuruoka N et al. (2002b) Mast cell chymase regulates dermal mast cell number in mice. Biochem Biophys Res Commun 290:1478-82
8. Tomimori Y, Tsuruoka N, Fukami H, Saito K, Horikawa C, Saito M et al. (2002c) Role of mast cell chymase in allergen-induced biphasic skin reaction. Biochem Pharmacol 64:1187
9. Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T et al. (2000) Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 67:585-9
10. Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, Fukuda Y (2002) Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 128:229-34
11. Weidinger S, Rummler L, Klopp N, Wagenpfeil S, Baurecht HJ, Fischer G et al. (2005) Association study of mast cell chymase polymorphisms with atopy. Allergy 60:1256-61
12. Yoshikawa T, Imada T, Nakakubo H, Nakamura N, Naito K (2001) Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 104: 333-40